Class / Patent application number | Description | Number of patent applications / Date published |
424680000 | Sodium chloride | 44 |
20090136598 | Compositions for the Treatment and Prevention of Eyelid Swelling - The invention features topical formulations comprising an osmotically active agent and/or a vasoconstrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof. | 05-28-2009 |
20090155386 | Method For Treating Agricultural Products Of Vegetable Origin and the Side-Products and/or Derivatives Obtained By Treatment - The present invention relates to a method to reduce the micro-biological load on agricultural raw materials, in which the agricultural raw materials are treated with an electrolysed saline solution, because of which the number of micro-organisms is reduced. With this method it will be possible to disinfect agricultural raw materials in a simple manner and at acceptable costs, without baleful consequences for the raw materials concerned. | 06-18-2009 |
20090155387 | STABLE PHARMACEUTICAL COMPOSITION COMPRISING BETA-LACTAM ANTIBIOTIC AND ION-CHELATING AGENT - A pharmaceutical composition comprising: at least one β-lactam antibiotic and at least one ion-chelating agent; wherein when said pharmaceutical composition is used as an anti-microbial drug, it optionally comprises further at least one aminoglycoside antibiotic. | 06-18-2009 |
20090258090 | COLON CLEANSING SOLUTION - The field of colonic diagnostic and surgical procedures is hampered by the lack of optimal means available to cleanse the colon. A compromise between convenient, distasteful, solid or low volume, hyperosmotic solutions which cause considerable fluid and electrolyte imbalances in patients and large volume, difficult to consume, iso-osmotic solutions has had to be made heretofore. This invention describes a low volume, hyper-osmotic solution consisting of sulfate salts with and with out polyethylene glycol, and further comprising a sweetener and/or flavoring. Unlike prior art, this composition is useful for the cleansing of the bowel and, in lower volumes, as a laxative, without producing clinically significant changes in bodily function. | 10-15-2009 |
20090274774 | Citrate-Based Dialysate Chemical Formulations - The present invention constitutes dialysate formulations that are suitable for use in preparing dialysate solutions for use in batch and/or proportioning systems and for improving dialysis efficiency by reducing or preventing clotting of the dialysis flow paths. The dialysate chemical formulations for one batch of dialysate comprise an acid concentrate stored in a first vessel, and a citrate-containing bicarbonate concentrate stored in a second vessel. The contents of the first and second vessels are emptied into a dialysate preparation tank and mixed with water to form a batch quantity of dialysate solution. Alternately, a dry acid and/or a dry citrate-containing base concentrates are dissolved separately in measured quantities of water to form liquid concentrates which are then used in conjunction with a proportioning machine to generate on-line a final dialysis solution stream. | 11-05-2009 |
20090297630 | Rectal Use of a Sodium Chloride Solution as an Intestinal Cleanser - Rectal use of a sodium chloride solution between 0.5% and 1.5% for rectal use, usable as an intestinal cleaner by simple mechanical action, used as an intestinal evacuator or cleaner in all those cases where intestinal evacuation is required, but without having any therapeutic effect, thus, avoiding side effects. | 12-03-2009 |
20090297631 | SALT COMPOSITIONS AND METHODS OF MAKING THE SAME - Disclosed is a method of preparing a salt composition comprising mixing a salt and an ingredient, pressing the salt and ingredient together under pressure to form an agglomerated salt and ingredient composition in the form of a sheet, briquette, pellet, flake or other form, and reducing the salt and ingredient composition into particulates having a desirable size, where the particulates form a substantially uniform blended product of the salt and the ingredient. In one embodiment, the salt composition may be sodium chloride or a sea salt and a seasoning or flavoring agent. | 12-03-2009 |
20100136140 | A USE OF HYPERTONIC SOLUTION COMPOSITION IN MANUFACTURING MEDICAMENTS FOR PROMOTING WOUND HEALING - A use of a hypertonic solution composition in manufacturing medicaments used during the perioperative period for promoting wound healing, said composition consists of 1.5%-6.9% (w/v) of one or more substances selected from sodium chloride, sodium bicarbonate, potassium chloride, magnesium sulfate, calcium chloride and calcium gluconate, 3%-18% (w/v) of one or more of the substances selected from hydroxyethyl starch, dextran, carboxymethyl starch, polyvinyl pyrrolidone and gelatin derivatives, and the remainder of conventional injection, provided that the amount of sodium chloride in the composition is not less than 1.5% (w/v), and the concentration of sodium ion is not more than the one equivalent to the concentration of sodium ion in 6.9% (w/v) sodium chloride solution. The hypertonic solution composition can be administered as transfusion before operation, during operation, after operation with the dose of 100-1500 ml/person/day, which can promoter wound healing. The hypertonic solution composition is advantageous in terms of the safety and convenience of application. Said composition can applied to various operative wounds or trauma wound (surface) as well as anastomotic stoma. | 06-03-2010 |
20100166885 | Resuscitation Fluid - The present invention relates to a resuscitation fluid which includes an ionic salt at a concentration above about 0.9%, at least one soluble protein, at least one intermediate energy substrate, and optionally an agent to mitigate intracellular acidosis. Methods of making and using the fluid are also described. | 07-01-2010 |
20100209540 | INHALATION FORMULATION FOR TREATING AND PROPHYLACTIC USE IN BACTERIA, MYCOBACTERIAL AND FUNGAL RESPIRATORY INFECTIONS - A composition for the treatment and prophylactic management of bacterial and fungal respiratory infections is provided. The composition may contain a combination of a quaternary ammonium compound and hypertonic saline to be administered to a patient in need thereof. | 08-19-2010 |
20100297264 | BOWEL PURGATIVE AND USES THEREOF - The present invention is directed to a dry composition for admixture with water for oral administration to a mammal and methods of using the composition for cleansing the bowel of a mammal in need thereof. | 11-25-2010 |
20110086114 | NASAL COMPOSITION - A nasal spray solution for use as a nasal spray and methods of using the solution are disclosed. The nasal spray solution moisturizes nasal passages and alleviates nasal dryness. The solution includes a hypotonic saline solution, wherein the saline solution is hypotonic with respect to cells of the nasal mucosa of the nasal passages, a buffering agent, a lubricating agent, and an anti-microbial agent. | 04-14-2011 |
20110111060 | COMPOSITIONS, FORMULATIONS, AND METHODS FOR PREVENTING AND/OR TREATING PHYSICAL EFFECTS OF ALCOHOL CONSUMPTION - The present invention provides effective novel compositions and formulations for treating and/or preventing a hangover. The present invention also provides methods for treating and/or preventing a hangover comprising administering the compositions and/or formulations of the present invention. | 05-12-2011 |
20110135757 | MICROAEROSOL-BASED DECONTAMINATION METHOD - A method for disinfection of a contaminated enclosed facility with microaerosol containing free radicals produced from an electrochemically-activated solution. In one embodiment of the invention the aerosol is produced from the EAS and air mixture at the air:EAS ratio (1-10):1 (by mass) with the droplets of ≦10 μm. This method is preferably performed by the atomization of the mixture with a vortex ejector nozzle with subsequent separation of coarsely dispersed particles. | 06-09-2011 |
20110142962 | Oral Rehydration Solutions Comprising Dextrose - The present disclosure is directed to oral rehydration solutions, and the use of these solutions to prevent dehydration due to fever. The oral rehydration solutions of the present disclosure may be oral rehydration solutions comprising about 12 mEq/L to about 18 mEq/L of sodium, from about 11 g/L to about 60 g/L of dextrose, a zinc source, and less than about 25 mEq/L of citrates. The pH of the oral rehydration solutions can be controlled by adjusting the amount of dextrose present in the oral rehydration solutions, allowing for formulation of oral rehydration solutions comprising lower levels of citrates. | 06-16-2011 |
20110171324 | METHOD OF TREATING OR PREVENTING DISEASE IN BEES - The invention is directed to a method of a method of treating or preventing disease in honeybees, a method of promoting the health of honey bees and to a method of increasing the production of honeybees in a hive or colony. | 07-14-2011 |
20110262562 | AQUEOUS SALINE SOLUTIONS FOR THE DESTRUCTION OF FATTY TISSUE - The invention relates to aqueous saline solutions with an osmolarity of 50 mOsm/L to 170 mOsm/L, which further include at least one membrane-weakening agent. The invention also relates to a cosmetic composition which includes one of said solutions, as well as to the use of one of said solutions to obtain a drug for treating cellulite, steatomery, and lipomas. | 10-27-2011 |
20120021072 | Compositions For The Treatment And Prevention Of Eyelid Swelling - The invention features topical formulations comprising an osmotically active agent and/or a vasoconstrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof. | 01-26-2012 |
20120045525 | MOSQUITO REPELLENT SOLUTION, PREPARATION METHOD AND USE THEREOF - A mosquito repellent solution to prevent mosquito bite, comprising 0.1-9.9% organic acid of total weight as active principle, 88-99.6% water as solvent. The organic acid is single acid or mixed composition out of ethyl butyrate, propionic acid, n-butyric acid, isobutyric acid, isobutyric, valeric acid, hexanoic acid, n-Heptanoic acid, L-Lactic Acid and malic acid. The composition solution to prevent mosquito bite disturb mosquitoes' olfactory sensation through imitating human's smell of skin and breath; all raw materials base on the standard of food grade, so the composition is safe to human beings, particularly to infant, pregnant women, children and the old who are weaker. The composition solution does not work by killing mosquitoes so it would not relate to resistance and ecology risk. The preparation method is simple with low costs; there is no three wastes and friendly to the environment. The composition solution applies to the preparation of preventing mosquito bite, relieving itching and detumescence, and air sterilization. | 02-23-2012 |
20120177751 | Pediculosis Treatment and Prophylaxis - Disclosed is a non-toxic composition and methods for controlling and preventing lice infestations. The composition of the invention controls louse populations with daily use. The composition of the invention may be used on the hair, body, and on inanimate objects. The viscous liquid composition of the invention may be applied as a shampoo, body cleanser, or detergent. | 07-12-2012 |
20120195980 | Method, Composition and Package for Bowel Cleansing - The present invention provides a highly palatable colon cleansing formulation that utilizes a low chloride electrolyte-replenishing base solution. When formulated with polyethylene glycol and a selected sugar alcohol, the formulation offers the advantages of superior palatability without undesirable concomitant side effects or a decrease in cleansing efficacy. | 08-02-2012 |
20120201903 | CYTOPROTECTIVE OR THERAPEUTIC PLANT COMPOSITION - Embodiments herein provide plant compositions, and, more specifically, a plant composition including | 08-09-2012 |
20120201904 | SKIN EXTERNAL COMPOSITION COMPRISING A SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND THE USE THEREOF - The present invention relates to a skin external composition comprising a combination of salt and sugar as an active ingredient in an amount effective to treat and prevent vaginosis, together with a pharmaceutically acceptable carrier, and the use thereof. | 08-09-2012 |
20130122116 | PAIN RELIEVER COMPOSITION - A pain reliever comprised of dextrose, aloe vera concentrate, and some or all of the following ingredients: propylene glycol, caprylic/capric tryglicerides, sodium chloride (or acetic acid), a homeopathic anti-inflammatory extract, Dimethyl Sulfone (or Methylsulfonylmethane (MSM)), cetyl myristoleate, and a pitcher plant extract. The resulting compositions are a water-based solution and two gel composition applied to the epidermis of mammals for relieving pain. | 05-16-2013 |
20130156868 | NASAL SPRAY - The invention relates to a medicinal product which is free from sympathomimetics, has an advantageous effect on the nasal mucosa in case of common colds, hay fever, dry nose and sympathomimetic dependencies, and is provided in the form of a nasal spray, a nasal douche or nasal drops. | 06-20-2013 |
20140017340 | SKIN EXTERNAL COMPOSITION COMPRISING A PURE SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND THE USE THEREOF - The present invention relates to a skin external composition comprising a combination of salt and sugar as an active ingredient in an amount effective to treat and prevent vaginosis, together with a pharmaceutically acceptable carrier, and the use thereof. | 01-16-2014 |
20140037758 | SKIN EXTERNAL COMPOSITION COMPRISING A MELTED SALT AND SUAGR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND THE USE THEREOF - The present invention relates to a skin external composition comprising a combination of salt and sugar as an active ingredient in an amount effective to treat and prevent vaginosis, together with a pharmaceutically acceptable carrier, and the use thereof. | 02-06-2014 |
20140065244 | Spray Method and Composition for Reducing Psychological Hunger - A spray composition and method are provided that are effective for reduction or elimination of the psychological hunger for foods for which a patient wishes to reduce consumption, Such ingredients preferably include but are not limited to cayenne pepper, alcohol, salt, citric acid and a sweetener such as saccharin plus ingredients that desensitize the taste buds and reduce hunger, including thymol, camphor benzoin and spearmint. The composition of the invention is preferably sprayed into the mouth, resulting in a lessening or elimination of psychological hunger. | 03-06-2014 |
20140170244 | 3,5-DIAMINO-6-CHLORO-N-(N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2- CARBOXAMIDE COMPOUNDS - The present invention relates compounds of the formula: | 06-19-2014 |
20140271928 | PLANT-BASED COMPOSITIONS AND USES THEREOF - The present invention relates to compositions comprising a plant material and methods for using the same. The methods include extracting or removing a substance from a substrate, or remediating a substrate from a substance. The substance can comprise a hydrocarbon-containing substance, a protein, lipid, wax, fatty acid or fatty alcohol, grease, fat, oil or a combination thereof. | 09-18-2014 |
20140302177 | SYSTEM AND METHOD FOR PATIENT PREPARATION - A method for preparing the human bowel to undergo colonoscopy. A salt solution, preferable having a 0.9% w/v concentration of sodium chloride in water and warmed to 40 C degrees, is utilized. A series of twisting and maneuvering exercises, such as those used in Yoga, is also performed. A predetermine quantity of the salt solution is consumed during predetermined intervals between the exercise steps, intending to clear and cleanse the colon so as to prepare it to undergo colonoscopy within about 3 to 24 hours after the completion of the preparation. | 10-09-2014 |
20140308371 | Acid Tablet Composition - A composition is described that includes: (a) at least one alkali metal hydrogen sulfate anhydrous, such as sodium hydrogen sulfate anhydrous; (b) at least one salt, that is different than the alkali metal hydrogen sulfate anhydrous, which is selected from alkali metal salt and/or alkaline earth metal salt, such as sodium chloride and/or magnesium sulfate; and (c) optionally a colorant, in which the composition is in the form of a tablet. There is also described a method of forming a treated aqueous stream using the tablet composition. There is further described a method of forming a treated sanitizing aqueous stream that involves combining the treated aqueous stream with a feed sanitizing aqueous stream. In addition, there is described a method of sanitizing a surface that involves applying the treated sanitizing aqueous stream to a surface to be treated, such as animal carcass surfaces. | 10-16-2014 |
20140356460 | Use of hypertonic saline to draw fluid out of swollen tissue and relieve nasal congestion - The optimum concentration of salt in solutions to combat congestion of the mucosa is a relatively narrow range. This use of in hypertonic saline solutions for treatment of congestion of the mucosa having a concentration within the range of 2.3% to and including 2.7% w/v sodium chloride/water with the most preferred concentration being 2.4% to and including 2.6% w/v of sodium chloride in water brings maximum relief of congestion and for cleansing membranes without causing irritation or discomfort. | 12-04-2014 |
20140377375 | SKIN EXTERNAL COMPOSITION COMPRISING A SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND THE USE THEREOF - A skin external composition comprising a combination of salt and sugar as an active ingredient in an amount effective to treat and prevent vaginosis, together with a pharmaceutically acceptable carrier, and the use thereof. | 12-25-2014 |
20150056305 | DITHIOL MUCOLYTIC AGENTS - Provided are dithiol mucolytic agents. These agents increase the liquefaction of mucus in a patient with excessive mucus or mucus with increased viscoelastic, cohesive, or adhesive properties. Also provided are a variety of methods of treatment using these inventive mucolytic agents. | 02-26-2015 |
20150299142 | 3,5-DIAMINO-6-CHLORO-N-(4-PHENYLBUTYL)CARBAMIMIDOYL) PYRAZINE-2-CARBOXAMIDE COMPOUNDS - The present invention relates compounds of the formula: | 10-22-2015 |
20150342987 | A use of the mixture of a salt and sugar in the manufacture of a medicament employed for treating Lax vegina syndrome or colpoxerosis disease in an mammal - The use of the mixture of a salt and sugar in the manufacture of a medicament employed for treating lax vagina syndrome or colpoxerosis disease in a mammal. Various tests, vaginal smooth muscle contractility test using New Zealand White Rabbit; (Experimental example 1); the effect on the vagina contractility in volunteers by using perinometer (Experimental example 2); and the effect on the colpoxerosis disease in volunteers (Experimental example 3), showed improving effect on the contractility of vagina tissue and colpoxerosis disease. Accordingly, the combination can be useful in treating or preventing lax vagina syndrome or colpoxerosis disease. | 12-03-2015 |
20150352102 | USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF ANAPHYLAXIS - The embodiments described herein include methods and formulations for treating anaphylaxis and related acute allergic reactions. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient. | 12-10-2015 |
20160040305 | APPARATUS AND METHOD FOR THE PRODUCTION OF AN ACID SUPER OXIDATION SOLUTION AND AN ALKALINE SOLUTION WITH INDEPENDENT FLOWS WITH ORP FROM AQUEOUS SOLUTIONS - This invention includes an electrolysis chamber and method for producing controlled flow acid electrolyzed water and controlled flow alkaline electrolyzed water with independent flows from aqueous solutions. Its objective is to produce controlled flow acid water with an oxide reduction potential (ORP) between +1100 and +1200 mV and a pH between 1.5 and 2.9 with a stability and shelf life of over a year, and controlled flow alkaline electrolyzed water with a pH between 9.0-11.0 and an ORP between −700 mV to −800 mV with a shelf life of more than a year. | 02-11-2016 |
20160051582 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CHRONIC PAIN - A pharmaceutical composition for treatment of chronic pain includes lidocaine, glucose, sodium chloride and sodium bicarbonate. The pharmaceutical composition could be applied for treatment of chronic pains in local position such as soft tissue, muscle tendon, synovial bursa. | 02-25-2016 |
20160083637 | METHOD FOR FREEZING AND THAWING ICE PARTICULATE FLUIDS - A frozen particulate slurry comprises a first component and a second component which are capable of forming a eutectic mixture. The slurry is formed by cooling a composition comprising the first and second components to a temperature below the freezing point of the first component to form particles of the first component, and then cooling to freeze a eutectic mixture of the first component and the second component. A method of thawing the frozen particulate slurry comprises heating the slurry, and an apparatus for thawing the frozen particulate slurry comprises a container for holding the particulate slurry, a heat source, and an agitator. A method of inducing therapeutic hypothermia in a patient comprises heating the frozen particulate slurry and administering the particulate slurry to the patient in an amount sufficient to locally or systemically induce therapeutic hypothermia. | 03-24-2016 |
20160131616 | LOW POLLUTANT DIALYSIS SOLUTION - The present invention relates to a method for determination of pollutants and leachables in dialysis solutions by stir bar sorptive extraction comprising the steps of
| 05-12-2016 |
20160194278 | DITHIOL MUCOLYTIC AGENTS | 07-07-2016 |
20160375053 | Use of the mixture of a salt and sugar in the manufacture of a medicament employed for treating lax vagina syndrome or colpoxerosis disease in an mammal - The use of the mixture of a salt and sugar in the manufacture of a medicament employed for treating lax vagina syndrome or colpoxerosis disease in a mammal. Various tests, vaginal smooth muscle contractility test using New Zealand White Rabbit; (Experimental example 1); the effect on the vagina contractility in volunteers by using perinometer (Experimental example 2); and the effect on the colpoxerosis disease in volunteers (Experimental example 3), showed improving effect on the contractility of vagina tissue and colpoxerosis disease. Accordingly, the combination can be useful in treating or preventing lax vagina syndrome or colpoxerosis disease. | 12-29-2016 |